Photo: Kristoffer Tripplaar / Sipa USA
Allergan will have to sell a product under development to treat inflammatory bowel diseases in order to secure final approval for the deal.
January 10, 2020 at 01:44 PM
1 minute read
The European Commission has cleared U.S. pharma company AbbVie’s proposed $63 billion acquisition of Ireland-based drug maker Allergan, provided the company sells one drug treatment currently in development.
Allergan will have to sell a product under development to treat inflammatory bowel diseases in order to secure final approval for the deal.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
